Metro Inc. (MRU)
Toronto Exchange · Canada · prices in CAD · close of 23 Oct 2026
Key indicators
| Last close | CAD 96.33 |
|---|---|
| 52-week range | 86.63 – 101.30 |
| Return, 1 month / 3 months | +6.8% / +6.2% |
| Return, 1 year / 3 years | +3.3% / +44.3% |
| Trend | Uptrend |
| RSI (14) | 64 |
| Volatility (1 year) | 18.9% |
| Worst drawdown (1 year) | -12.5% |
| Average daily value traded | 59.21M CAD |
| Dividend yield | 2.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Metro Inc. is a Canadian retailer of food and pharmacy products based in Montreal. It serves everyday shoppers through a family of grocery banners, including conventional supermarkets, discount stores and neighbourhood markets, alongside pharmacy chains that dispense prescriptions and sell health and beauty products. Its stores are supplied partly by the company's own distribution centres and food production facilities, and it serves customers across several Canadian provinces through both corporate and franchised locations.
The shares are listed on the Toronto Exchange in Canada under the code MRU, and the price on this page is in Canadian dollars (CAD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Metro Inc. (MRU) trades on the Toronto Exchange in Canada. It last closed at CAD 96.33 on 23 October 2026.
Its price-based Market X-Ray is 70 out of 100 (a fair price profile), ranking 134 of 870 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 3.3% and over the last three months it rose 6.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Toronto Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 63 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 4.6% | ||
| From 52-week high | -4.4% | ||
| Momentum | 58 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 6.2% | ||
| 6-month return | 8.2% | ||
| 12-month return, skipping the last month | -3.3% | ||
| Stability (higher is calmer) | 89 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 18.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -12.5% | ||
| Liquidity | 92 · Strong | Trades actively. | |
| Average daily value traded | 59.21M CAD | ||
| Zero-volume days | 0.0% | ||
| Income | 34 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.1% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | −0.8% |
|---|---|
| 1 month | +6.8% |
| 3 months | +6.2% |
| 6 months | +8.2% |
| 1 year | +3.3% |
| 3 years | +44.3% |
| 5 years | +66.3% |
Signals
| 50-day / 200-day average | 90.63 / 92.06 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.79 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 22 Oct 2026 | CAD 0.4075 |
| 4 Sep 2026 | CAD 0.4075 |
| 13 May 2026 | CAD 0.4080 |
| 12 Feb 2026 | CAD 0.4080 |
| 23 Oct 2025 | CAD 0.3700 |
| 4 Sep 2025 | CAD 0.3700 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Toronto Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.